Biopharmaceutical Industry in Belgium: Market Research Reports, Statistics and Analysis

You might be interested in: protein, antibody, enzyme, more »

» Download Public Reports

7 reports
Company Report: Biopharmaceutical in The United States and Europe for Year 2012

Company Report: Biopharmaceutical in The United States and Europe for Year 2012

  • Company report
  • April 2012
  • 2 pages

... About thrombogenics thrombogenics is a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines. The company S lead product, ocriplasmin, has successfully ...

Company Report: Biopharmaceutical In The United States And Europe ...

December 2011

Company Report: Biopharmaceutical In Belgium For Year 2012

November 2012

Company Report: Biopharmaceutical In Belgium For Year 2012

November 2012

Biopharmaceutical Market In Belgium And China

May 2011

Biosimilar Market Analysis In Belgium

May 2012

» Purchase Premium Reports (From $ 125 - $ 125)

11 reports
Ablynx NV (Symbol:ABLX) SWOT Analysis, Strategy, Revenues and Profits

Ablynx NV (Symbol:ABLX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...


Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.